Genomic biomarkers in predictive medicine: an interim analysis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.Genes · 2025
   Review
2. Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.Cancers · 2025
   Article
3. Unveiling the Digital Evolution of Molecular Tumor Boards.Targeted oncology · 2025
   Review
4. Transforming Clinical Research: The Power of High-Throughput Omics Integration.Proteomes · 2024
   Review
5. Predictive Modelling in Clinical Bioinformatics: Key Concepts for Startups.Biotech (Basel (Switzerland)) · 2022
   Article
6. Progress Toward a Multiomic Understanding of Traumatic Brain Injury: A Review.Biomarker insights · 2022
   Review
7. Detecting survival-associated biomarkers from heterogeneous populations.Scientific reports · 2021
   Article
8. A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic.The Journal of pharmacology and experimental therapeutics · 2021
   Review
9. The Current State of MicroRNAs as Restenosis Biomarkers.Frontiers in genetics · 2019
   Review
10. Surviving With Smog and Smoke: Precision Interventions?Chest · 2017
    Review
11. Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.Oncotarget · 2017
    Article
12. Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons.BMC genomics · 2016
    Article
13. Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data.Oncotarget · 2016
    Article
14. Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?BMC clinical pathology · 2016
    Article
15. Microarray Meta-Analysis and Cross-Platform Normalization: Integrative Genomics for Robust Biomarker Discovery.Microarrays (Basel, Switzerland) · 2015
    Review
16. Genomic biomarkers of SUDEP in brain and heart.Epilepsy & behavior : E&B · 2014
    Review
17. Fool's gold, lost treasures, and the randomized clinical trial.BMC cancer · 2013
    Article
18. Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.BioMed research international · 2013
    Article
19. Comprehensive literature review and statistical considerations for microarray meta-analysis.Nucleic acids research · 2012
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as